CFS Investment Advisory Services’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
3,737
+11
+0.3% +$3.34K 0.09% 168
2026
Q1
$997K Buy
3,726
+102
+3% +$22.8K 0.07% 196
2025
Q4
$620K Sell
3,624
-197
-5% -$30.6K 0.05% 220
2025
Q3
$580K Sell
3,821
-363
-9% -$38.4K 0.04% 225
2025
Q2
$407K Buy
4,184
+11
+0.3% +$872 0.03% 243
2025
Q1
$303K Sell
4,173
-31
-0.7% -$2.44K 0.03% 265
2024
Q4
$304K Buy
4,204
+184
+5% +$14K 0.03% 255
2024
Q3
$328K Sell
4,020
-3,280
-45% -$285K 0.03% 240
2024
Q2
$778K Buy
+7,300
New +$700K 0.06% 160
2023
Q3
Sell
-4,150
Closed -$267K 212
2023
Q2
$267K Buy
+4,150
New +$234K 0.03% 216
2022
Q2
Sell
-913,940
Closed 395
2022
Q1
$0 Buy
+913,940
New +$53.2M ﹤0.01% 490

Other funds holding LRCX

CFS Investment Advisory Services's LRCX Position: Q2 2026 in Review

CFS Investment Advisory Services increased its Lam Research (LRCX) stake by 0.3% in Q2 2026, buying an estimated $3.34K and bringing the position to 3,737 shares worth $1.31M. The position accounts for 0.09% of the portfolio, ranked #168.

CFS Investment Advisory Services first reported a position in LRCX in Q1 2022 and has held it in 11 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • CFS Investment Advisory Services held 3,737 shares of Lam Research worth $1.31M as of Q2 2026.
  • CFS Investment Advisory Services bought 11 Lam Research shares in Q2 2026, an estimated $3.34K.
  • Lam Research made up 0.09% of CFS Investment Advisory Services's portfolio in Q2 2026, its #168 holding.
  • CFS Investment Advisory Services first reported a position in Lam Research in Q1 2022 and has held it in 11 quarters since.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on CFS Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.